Web Results



Feb 1, 2016 ... TECHNOLOGIES,. Plaintiffs-Appellants v. EPIC PHARMA, LLC,. Defendant ... Purdue Pharma L.P., The P.F. Laboratories, Inc., Purdue.

Purdue Pharma v Epic Pharma | www.krameramado.com


Feb 29, 2016 ... Purdue Pharma L.P. et al v. Epic Pharma LLC et al. Appeal Nos. 2014-1294, - 1296, -1306, -1307, -1312, -1313, -1314 (Fed. Cir. February 1 ...

Supreme Court Patent Cases: Malpractice, Obviousness, and Venue ...


Sep 18, 2016 ... Teva and Purdue v. ... disclosed by the prior art for anticipation purposes); Obviousness: Purdue Pharma L.P. v. Epic Pharma, LLC, 16-289 (whether the circumstances of invention can ... Post Grant Admin: Merck & Cie, et al. v.

On Appeal, Abuse-Deterrent OxyContin Patents are Invalid | Patently ...


Feb 1, 2016 ... Purdue Pharma v. Epic Pharma (Fed. ... the lower court's holding that Purdue Pharma's abuse deterrent OxyContin patent claims are invalid as anticipated and /or obvious over the prior art.[2] ... Xicor LLC, 692 F.3d 1261 (Fed.

Federal Circuit Case Updates: McKool Smith


... LLC v. Apple Inc. In re: Magnum Oil Tools; Verinata Health, Inc. et al. v. ... Glenmark Pharmaceuticals Inc. USA; Diamond Coating Technologies, LLC v. ... MPHJ Technology Investments, LLC; Rembrandt Vision Technologies, L.P. v. ... L.P. v. Epic Pharma, LLC; The Trustees of Columbia University in the City of New York v.

ANDA Update - July 2016 | 07 | 2016 | Newsletters | Thought ...


Jul 5, 2016 ... Purdue Pharma L.P. v. Epic Pharma, LLC., 811 F.3d 1345 (Fed. ..... Inc. v. Sylvia M Burwell, et al., 2016 WL 1060199 (D.D.C. March 15, 2016)(J.

Reformulated OxyContin Patents Invalid - Lexology


Mar 30, 2016 ... Purdue Pharma L.P., et al. v. Epic Pharma, LLC, et al. Addressing product-by- process limitations and inherent anticipation issues, the US Court ...

Selected Publications | The Center for Intellectual Property Research


The Law and Politics of Pharmaceutical Patents in India, in PERSPECTIVES ON INNOVATION AND IPRS IN CHINA ... L.P., The P.F. Laboratories, Inc., Purdue Pharmaceuticals L.P., and Rhodes Technologies v Epic Pharma, LLC (Fed. ... Amicus Brief with the U.S. Supreme Court in Retractable Technologies, Inc., et al. , v.

Litigation_Buzz_201608a - American Intellectual Property Law ...

www.aipla.org/committees/committee_pages/Biotechnology/litigation/Shared Documents/Litigation_Buzz_201608a.pdf

Aug 1, 2016 ... See Shire LLC v. Amneal ... 35 U.S.C. § 316(e). See also Purdue Pharma. L.P. v. Depomed, Inc., Nos. 2015-2029 ... Pasteur & Universite Pierre et Marie Curie v. Focarino, 738 F.3d ..... H. South Alabama Medical Science Foundation v. Gnosis S.P.A., 808 .... L.P. v. Epic Pharma LLC, 811 F.3d 1345 (Fed. Cir.

Nationwide Appellate & Trial - Jones Day Issues & Appeals


Purdue Pharma L.P. v. Epic Pharma, LLC, Fed. Cir. 10/06/14, Brief of Plaintiff- .... 53. City of Cleveland v. Ameriquest Mortgage Securities, Inc., et al. 6th Cir.

More Info

Fed. Circ. Affirms Ruling Axing 4 Purdue OxyContin Patents - Law360


Feb 1, 2016 ... The case is Purdue Pharma LP v. Epic Pharma et al., case number 2014-1294, of the U.S. Court of Appeals for the Federal ... Epic Pharma, LLC ...

Purdue Pharma L.P. v. Epic Pharma, LLC | Robins Kaplan LLP


Apr 7, 2016 ... Case Name: Purdue Pharma L.P. v. Epic Pharma, LLC, 811 F.3d 1345 (Fed. Cir. Feb. 1, 2016) (Circuit Judges Prost, Reyna, and Stark [sitting ...

Supreme Court Patent Cases: - Patently-O


Nov 14, 2016 ... Anticipation/Obviousness: Merck & Cie, et al. v. ... prior art for anticipation purposes); Obviousness: Purdue Pharma L.P. v. Epic Pharma, LLC, 16-289 ( whether the circumstances of invention can help prove non-obviousness) ...